Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021

SELL
$187.49 - $221.1 $29,248 - $34,491
-156 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$207.02 - $241.31 $414 - $482
2 Added 1.3%
156 $34,000
Q4 2020

Feb 11, 2021

SELL
$207.01 - $276.09 $621 - $828
-3 Reduced 1.91%
154 $36,000
Q3 2020

Nov 09, 2020

BUY
$255.65 - $303.1 $766 - $909
3 Added 1.95%
157 $43,000
Q2 2020

Aug 12, 2020

SELL
$225.48 - $295.8 $225 - $295
-1 Reduced 0.65%
154 $45,000
Q1 2020

May 12, 2020

BUY
$199.77 - $247.81 $998 - $1,239
5 Added 3.33%
155 $37,000
Q4 2019

Feb 10, 2020

SELL
$166.71 - $223.91 $10,002 - $13,434
-60 Reduced 28.57%
150 $33,000
Q3 2019

Nov 13, 2019

BUY
$166.23 - $187.09 $498 - $561
3 Added 1.45%
210 $36,000
Q2 2019

Aug 08, 2019

SELL
$164.61 - $190.37 $37,366 - $43,213
-227 Reduced 52.3%
207 $38,000
Q1 2019

May 14, 2019

SELL
$163.73 - $194.7 $44,534 - $52,958
-272 Reduced 38.53%
434 $80,000
Q4 2018

Feb 06, 2019

BUY
$151.91 - $192.21 $1,367 - $1,729
9 Added 1.29%
706 $117,000
Q3 2018

Nov 13, 2018

BUY
$167.73 - $192.74 $838 - $963
5 Added 0.72%
697 $134,000
Q2 2018

Aug 09, 2018

BUY
$145.72 - $169.96 $73,297 - $85,489
503 Added 266.14%
692 $118,000
Q1 2018

May 14, 2018

SELL
$151.6 - $177.13 $55,485 - $64,829
-366 Reduced 65.95%
189 $0
Q4 2017

Feb 13, 2018

SELL
$137.28 - $155.55 $177,914 - $201,592
-1,296 Reduced 70.02%
555 $83,000
Q3 2017

Nov 13, 2017

BUY
$148.13 - $162.24 $274,188 - $300,306
1,851
1,851 $281,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $102B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Sun Life Financial Inc Portfolio

Follow Sun Life Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sun Life Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sun Life Financial Inc with notifications on news.